Merrimack Pharmaceuticals, Inc. | |||||
Selected Balance Sheet Data (unaudited) | |||||
(in thousands) | March 31, 2019 | December 31, 2018 | |||
Cash, cash equivalents and marketable securities | $ 58,466 | $ 71,278 | |||
Working capital | 51,880 | 61,307 | |||
Total assets | 74,353 | 88,543 | |||
Total liabilities | 25,389 | 29,724 | |||
Total stockholders' equity | 48,964 | 58,819 |